Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Get Answers Now
A.RiedtC
In the phase 3 trials with once-weekly icodec in T2DM, glycaemic control was achieved with low risk of hypoglycaemia and the general safety profile was broadly similar to once-daily degludec or once-daily glargine U100, including low incidence of hypersensitivity events in all treatment arms [13, 14, 28, 29]
Red flags (When to Call/ER) While most GLP-1 side effects are mild and manageable, there are a few rare but serious side effects that require immediate medical attention
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 25.39
US$ 22.52
US$ 20.78
US$ 20.75
US$ 21.45
